Abstract
Gliomas are the most common primary brain tumors. Despite the implementation of therapeutic strategies, these tumors remain fatal. The recent advances in the field of stem cell biology, cell signaling, genomics, bio-informatics and genetic model systems have led to a better understanding of gliomas biology. These advances are facilitating the establishment of a more precise, molecular-based, classification of gliomas and are leading to new therapeutic strategies directed against the key molecular events implicated in gliomas oncogenesis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
